The Effect of Quinidine on Calcium Accumulation by Isolated Sarcoplasmic Reticulum of Skeletal and Cardiac Muscle by Fuchs, Franklin et al.
The  Effect  of Q uinidine  on Calcium 
Accumulation  by Isolated  Sarcoplasmic 
Reticulum of Skeletal and Cardiac Muscle 
FRANKLIN  FUCHS,  EDWARD  W. GERTZ,  and 
F.  NORMAN  BRIGGS 
From the  Department of  Physiology,  University  of  Pittsburgh  School  of  Medicine, 
Pittsburgh,  Pennsylvania  15213 
ABSTRACT  Quinidine potentiates twitch tension and (at  higher concentra- 
tions) causes contracturc  of skeletal  muscle whereas  the same  drug reduces 
tension  development of  cardiac muscle. To gain insight  into  the possible  differ- 
ences in the excitation-contraction  coupling mechanism  of the two types of 
muscle the  effect  of  quinidinc on calcium accumulation by  isolated  sarcoplasmic 
rcticulum from skeletal  and cardiac muscle was investigated.  In a medium con- 
taining  ATP, Mg ++,  oxalatc,  and ~Ca, pharmacologically active  concentrations 
of  the  drug inhibited  calcium accumulation by both skeletal  and cardiac sarco- 
plasmic rcficulum. The inhibition  of  the rates  of  calcium uptake by the  skeletal 
muscle  preparation  ranged  from I  1% with I0  --4  u quinidinc to 90  %  with I0  "s M 
quinidinc.  With the  cardiac muscle preparation the  inhibition  ranged from 16  % 
with 3 X  I0  -e  ~ quinidinc to I00% with 10  -s  M quinidinc.  With both prepara- 
tions  the inhibition  of  calcium transport  was accompanied  by an inhibition  of 
the Ca++-activatcd ATPasc  activity  of the sarcoplasmic  rcticulum. The effect 
of quinidinc  on the skeletal  sarcoplasmic  rcticulum supports  the hypothesis 
that this  compound  produces  twitch potentiation and contracturc  by inter- 
fering  with  intraccUular  calcium  sequestration.  Its  effect  on  cardiac  sarcoplasmic 
rcticulum has bccn interpreted in terms of the hypothesis that cardiac con- 
tractility  is  a function of  the amount of  calcium released  from the sarcoplasmic 
rcticulum which is  in turn dependent upon the absolute calcium content of  the 
rcdculum. Hence, following inhibition  of  calcium transport  there  would bc less 
calcium available  for coupling. 
INTRODUCTION 
The alkaloid quinidine (and its optical isomer quinine) has opposite effects on 
skeletal and cardiac muscle. Low concentrations of quinidine  (10-L10  -~ M) 
cause a  potentiation of twitch tension of skeletal muscle, whereas higher con- 
centrations  (~  10  -8 u)  cause contracture  (1-4).  In contrast,  the depressant 
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effect of this  drug on  cardiac contractility has  been well-established  (5-8). 
On the basis of studies with isolated rabbit atria (5) and cat papillary muscle 
(7)  it  would  appear  that  quinidine  concentrations  of ~10 -6  v~  or  greater 
cause a  significant reduction in myocardial tension development. Thus in its 
pharmacological effects quinidine bears at least a  superficial resemblance to 
NO3-, Zn  ++, and UO,  ++, all of which have been reported to enhance skeletal 
muscle tension (9) but depress cardiac contractility (10-12). 
It has been established that in both skeletal and cardiac muscle contraction 
is coupled to excitation through the release of calcium from the sarcoplasmic 
reticulum (13-16). There is a growing body of evidence suggesting that drugs 
which alter the contractile states of both types of muscle do so through their 
ability to act on the intracellular calcium stores of the muscle, in particular 
those of the sarcoplasmic reticulum (16). 
In the case of skeletal muscle it has been suggested that drugs which cause 
twitch potentiation and contracture (e.g. caffeine, quinidine) act directly on 
the sarcoplasmic reticulum to cause a  release of calcium or inhibition of the 
calcium transport system, thereby raising the free myoplasmic calcium con- 
centration  (13).  This  hypothesis is  supported  by  tracer studies  carried  out 
with  living  frog muscles which  show  that  these  agents  do  indeed  cause  a 
release of intracellular calcium (4,  17). There are also reports indicating that 
these drugs can release a  fraction of the calcium bound  by isolated  sarco- 
plasmic reticulum (4,  18,  19). 
Much less information is available on the regulation of intracellular calcium 
movement in cardiac muscle. According to the hypothesis of Gertz et al.  (20) 
cardiac contractility is directly related to the absolute calcium content of the 
sarcoplasmic reticulum. In terms of this hypothesis any agent which inhibits 
sarcotubular calcium transport will reduce the amount of calcium available 
for coupling and thus cause depression of tension development. 
As suggested earlier by Sandow (9), an agent such as quinidine, which has 
well-defined but opposite effects on skeletal and cardiac muscle, might be a 
useful tool for delineating the differences in the coupling mechanisms in the 
two types of muscle. With this end in mind we have investigated the effects 
of quinidine on the ATP-dependent calcium accumulation by sarcotubular 
vesicles isolated from rabbit skeletal muscle and canine myocardium. 
METHODS 
Preparation of Sarcotubular Fraction 
Skeletal muscle sarcotubular vesicles were prepared from minced back and leg muscles 
of the rabbit. After being chilled on ice, the muscle tissue was homogenized for 1 min 
in a V(aring Blendor in 4 volumes of 0.3 M  sucrose,  10 mM imidazole, pH 7.0. Follow- 
ing centrifugation to remove myofibrils ( 1500 g X  90 rain) and mitochondria ( 10,000 
g X  20 rain), the sarcotubular fraction was collected by centrifugation at 30,000 g for F~NxLX~ Fucm ~.T AL.  Effect  of Quinidine  on Sarcoplasmie  Reticulum  957 
1 hr. The vesicles were washed once with sucrose solution and finally suspended, with 
the aid of a glass Teflon homogenizer, in a small volume of sucrose solution to a final 
protein concentration of 4-6 mg per ml. The entire procedure was carried out in a 
cold room at 4°C. The protein concentration of the suspension was determined ac- 
cording to Lowry et al. (21), using bovine serum albumin as a standard. 
For the preparation of cardiac sarcotubular vesicles, an approximately 20 kg dog 
was  anesthetized with sodium pentobarbital (25 mg/kg)  and  maintained  on  100% 
oxygen by endotracheal intubation.  The heart was  removed as quickly as possible, 
rinsed with  ice-cold saline,  cut into small  pieces,  and  cooled in  crushed ice.  After 
removing fat  and  connective tissue  the ventricular  muscle  was  homogenized  in  a 
Servall Omnimixer for 40 sec with 4  volumes of 0.3  M sucrose,  10  rnM  imidazole, 
pH 7.0.  Following centrifugation for removal of myofibrils ( 1000 g  X  15 roan) and 
mitochondria (12,000 g  X  25 min), the sarcotubular vesicles were collected by cen- 
trifugation at 65,000 g  for 70 min. The vesicles were washed by suspending them in 
fresh sucrose solution and recentrifuging them at  150,000 g  for 30 min. The vesicles 
were finally suspended in a small volume of sucrose solution to a protein concentration 
of ~20 mg per ml. Some of the preparations were suspended in 45 % sucrose to stabil- 
ize them (22). High concentrations of sucrose have been found to inhibit the destruc- 
tion of the vesicles by lysosomal enzymes (23). 
Measurement of Calcium Accumulation 
The rate of calcium uptake by sarcotubular vesicles was measured by the Mfllipore 
filtration technique (24) as described in the paper of Gertz et al. (20). Filters of 0.45/z 
pore diameter were used throughout. The incubation medium for the skeletal muscle 
preparation contained  100 mM KCI, 20 m_M imidazole, pH 7.0, 4  rnM MgCA~, 4  m_~ 
K  oxalate, 0.1 mM CaC1,., 0.1  /ac per rrd 46Ca, 4-5 m_M ATP, and 0.02 mg per rrd pro- 
tein.  Incubations were carried out at room temperature (20-22°C). The incubation 
medium for the cardiac muscle preparation contained 104 inM KC1, 19 m_M imidazole, 
pH  7.0,  5  rnM MgCI~,  1.8  m.M K  oxalate, 0.09 or 0.18 m_M CaCI,.,  0.05  /zc per ml 
45Ca, 5 m_~ ATP, and 0.15 mg per rrd protein. The incubation temperature was 37°C. 
Measurement of Adenosinetriphosphatase Activity 
ATPase activity was determined from the rate of liberation of inorganic phosphate. 
Following  the  addition  of ATP,  2  ml  aliquots  of the  incubation  mixture were re- 
moved at various times and pipetted into test tubes eontaining 2 rnl of ice-cold 10% 
trichloroacetie acid and 200 mg of acid-washed Norit A. The charcoal was added to 
adsorb the quinidine (25), since the latter compound interferes with the phosphate 
determination. The charcoal and denatured protein were removed by filtration and 
the phosphate concentration of the filtrate was determined according to the method 
of King (26). The skeletal muscle preparations were incubated at 25°G in the same 
medium used for the measurement of calcium uptake. The cardiac muscle prepara- 
tions were incubated at 37°C in either the same medium used for the measurement 
of calcium uptake by the cardiac vesicles or in the skeletal muscle medium. The results 
were the same in either case. The ATPase activity was assayed by measuring the rate 
of phosphate liberation before and after the addition of 0.1  mM CaCI2 (27). The Ga  ++- 958  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  5 2  -  i968 
activated ATPase associated  with calcium transport (27)  was  calculated from the 
difference in slopes of the curves before and just after the calcium addition. 
Solutions and Reagents 
All solutions were prepared with distilled,  deionized water. The ATP  I was a product 
of P-L Biochemicals, Milwaukee, Wis., and quinidine sulfate was obtained from Sigma 
Chemical Co., St. Louis, Mo. 
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FiGures 1.  The effect of quinidine on the kinetics of calcium uptake by skeletal muscle 
sarcoplasmlc reticulum. Quinidine concentrations  are indicated on right. See "Methods" 
section for experimental conditions. 
RESULTS 
Skeletal Muscle Sarcoplasmic Reticulum 
The effect of quinidine on the kinetics of calcium transport by isolated sarco- 
plasmic reticulum of skeletal muscle is illustrated in Fig.  1. The initial rates 
of calcium uptake of the controls were in the range of I-2 #moles Ca  ++ per 
mg  per  min,  in  good  agreement with  values  recorded  by  others  (14)  for 
oxalate-dependent calcium transport. As seen from the data in Fig. 2 quini- 
dine exerted no discernible effect on calcium uptake at concentrations less 
than  10  -* M. With higher concentrations there was an inhibition of calcium 
uptake which was a  linear function of the logarithm of the quinidine con- 
centration. An average inhibition of 90~ was obtained with 10  -3 M quinidine. 
The effect of quinidine on  the sarcotubular ATPase activity is  shown in 
Figs. 3 and 4. As first observed by Hasselbach and Makinose (27), the addition 
of calcium (0.1  rnM) to a  suspension of sarcotubular vesicles in the presence 
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of ATP,  Mg++,  and  oxalate  caused  an  immediate  burst  of ATP  hydrolysis 
associated with the transport  of calcium into  the interior  of the vesicles.  On 
the average there was an approximately  10-fold increase in the rate of ATP 
hydrolysis following the addition of calcium.  In the presence of quinidine  the 
degree of calcium activation was markedly reduced  (Fig.  3).  In the range of 
quinidine  concentrations  which  produced  inhibition  of  calcium  transport 
(10-4-10  -3)  there  was  an  increasing  inhibition  of  Ca++-activated  ATPase 
activity as the quinidine  concentration  was increased  (Fig.  4).  Inasmuch  as 
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Fmug]~ 2.  Relative  rates of calcium  uptake by skeletal muscle sarcoplasmJc  reticulum 
as a function of quinidine concentration. Figures in parentheses indicate  the number of 
measurements and the vertical bars indicate the standard error. The absolute values for 
the controls were in the range of I-2/zmoles Ca  ++ per mg per rain. See Methods section 
for experimental conditions. 
the  free  calcium  concentrations  were  not  controlled  with  a  calcium  buffer 
system and calcium uptake and ATPase measurements were made on different 
samples of vesicles, these data can only be considered to be semiquantitative. 
Further  studies  are  needed  to  determine  the  precise  relationship  between 
ATPase inhibition  and inhibition of calcium transport. 
Cardiac Muscle Sarcoplasmic Reticulum 
The effect of varying  concentrations  of quinidine  on  the calcium uptake  of 
isolated cardiac sarcoplasmic reticulum is illustrated in Fig. 5. The initial rates 
of calcium accumulation  by the controls were in the range of 0.2-0.4 #mole 960  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  5 2  •  z968 
Ca  ++ per mg per min, in good agreement with previous values obtained in this 
laboratory (20).  Inhibition ranged from an average of 16% with 3  X  10  -6 M 
quinidine  to  100% with  10  -8 ra quinidine.  Thus  the  effect of quinidine  was 
qualitatively similar  to  that  seen  with  the  skeletal  muscle  preparation.  The 
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FIOUR~ 3.  The effect of 10  -8 M quinidine on the Ca++-activated  ATPase of skeletal 
muscle sarcoplasmic reticulum. See Methods section for experimental conditions. At time 
indicated by arrow CaCI2 was added to a concentration of 0.1 m_M. Protein concentra- 
tion, 0.05 nag per ml. 
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main  difference was  in  the  greater  sensitivity of the  cardiac  preparation  to 
lower concentrations  (10-6-10  -4 M)  of quinidine. 
Also  shown  in  Fig.  5  is  the  effect of quinidine  on  the  isometric  tension 
development  of cat  papillary  muscle,  taken  from  the  data  of Parmley  and 
Braunwald  (7). The curve relating tension to quinidine concentration follows 
the same general shape as the curve relating calcium uptake to quinidine con- 
centration but is shifted somewhat to the right.  Considering the species differ- 
ence and the inevitable difficulty in  comparing experiments made with intact FRAI~Ln~ Fucm ET AL.  Effect of Quinidine  on Sarcoplasmi¢ Reticulum  96I 
tissues  and subccUular systems, the correspondence between the two sets  of 
data is  reasonably good and lends  support  to  the  possibility  that  the  negative 
inotropic  action of  quinidine is  related to the inhibition  of the sarcotubular 
calcium pump. 
The effect  of  quinidine on the  Ca++-activated ATPase of  the  cardiac sarco- 
tubular vesicles  was essentially  the same as that  observed with the skeletal 
muscle  preparations (Figs.  6 and 7). 
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Relative rates  of calcium uptake by cardiac sarcoplasndc reticulum as a 
function  of quinidine  concentration.  Figures in  parentheses  indicate  the  number  of 
measurements and the vertical bars indicate the standard error. The absolute values for 
the controls were in the range of 0.2-0.4 #mole Ca  ~-~ per mg per min.  See Methods 
section for experimental conditions. Also shown is the effect of quinidine on isometric 
tension  development by cat  papillary muscle,  taken  from  the  data  of Parmley and 
Braunwald (7). 
DISCUSSION 
The data presented in this report clearly show that quinidine strongly inhibits 
the transport of calcium into the sarcoplasmic reticulum of both skeletal and 
cardiac muscle. Q,uinidine readily passes through cell membranes, including 
those of muscle  (28).  The concentrations of quinidine which inhibited the 
sarcotubular calcium pump in this study closely approximated the pharmaco- 
logically active concentrations. It seems safe to conclude that in the intact cell 
the calcium pump is inhibited under conditions in which the drug alters the 
contractility of the cell. Since the intracellular free calcium concentration is 
the  critical  determinant of contractile  force development in  both  types of 
muscle, the question which must be raised is how inhibition of the sarcotubular 
calcium pump can be associated with increased force development in skeletal 
muscle and decreased force development in cardiac muscle. There would ap- 
pear  to  be  a  fundamental difference between  the  two  types  of muscle as 962  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  5 2  •  1968 
regards the regulation of intracellular calcium movements. A  similar conclu- 
sion was reached by Nayler  (12)  on the basis of her studies of the effects of 
certain inorganic ions  (NO3-,  Zn  ++, UO2 ++) on cardiac contractility. 
According to the hypothesis of Isaacson and Sandow (4)  alkaloids such as 
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sarcoplasmic reticulum.  See Methods  section for experimental conditions. At time indi- 
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FIGURE 7.  The effect of variation in quinidine concentration on the Ca++-activated 
ATPase activity of cardiac sarcoplasmic reticulum. See  Methods section for experi- 
mental conditions. Protein concentration, 0.1 mg per ml. 
quinine (or quinidine) and caffeine cause twitch potentiation and contracture 
of skeletal muscle by virtue of their ability to cause an increased calcium flux 
from sarcoplasmic reticulum to myoplasm. They suppose that low concentra- 
tions of quinidine (10 .4 u  or less), acting directly on the sarcoplasmic reticu- 
lum, cause the release of an amount of calcium which by itself is subthreshold 
for the activation of contraction but which, when added to the calcium nor- 
mally released  by  the  action potential,  causes a  prolongation of the  active FRANKLIN  FUCHS ET  AL.  Effect  of Quinidine on Sarcoplasmic Reticulum  963 
state and, hence, an increase in twitch tension. With higher concentrations 
( >  5  X  10  -4 M) the amount of calcium released by the drug would be sufficient 
to  activate  the  contractile mechanism and  thus  produce contracture. The 
data presented here are compatible with this hypothesis.  Thus in  the con- 
centration range associated with twitch potentiation  (10-L10  -4 M) quinidine 
had little or no effect on calcium accumulation. This would not rule out small 
in situ effects since in a study of the type reported here an average inhibition 
of,  say 5°~, could easily have escaped detection. All other factors remaining 
equal, the same degree of in situ inhibition would ultimately lead to an eleva- 
tion of the free intracellular calcium concentration. With 10  -4 M quinidine we 
observed an average inhibition of 11°~ whereas at 5  X  10  -4 M there was an 
average inhibition of 64°-~. In comparison, Isaacson and Sandow  (4)  found 
that  10  -4  M quinine,  which  under  their  conditions  only  produced  twitch 
potentiation,  caused a  20°-~ increase in  the rate coefficient for 46Ca efflux 
from frog sartorius muscle whereas 5  X  10  -4 M quinine, which was roughly 
the threshold concentration for contracture, caused a  320°-~ increase in the 
rate coefficient. Considering the differences in  experimental materials and 
conditions the two sets of data correspond reasonably well and lend support to 
the hypothesis that the twitch potentiation and contracture of skeletal muscle 
induced by quinidine  (or quinine)  are causally related to  the same mech- 
anism,  namely inhibition  of sarcotubular calcium accumulation. To  what 
extent the rise in myoplasmic calcium concentration produced by low con- 
centrations of quinidine would in fact account for twitch potentiation is not 
clear in the absence of quantitative information on the intracellular calcium 
concentrations and fluxes. Even if no additional calcium were released by the 
drug, inhibition of the calcium pump would prolong the active state by virtue 
of the longer period of time after the action potential in which the myoplasmic 
calcium concentration remains elevated above the threshold level.  In other 
words, the important factor in prolongation of the active state is not the pres- 
ence of a  supernormal free calcium concentration but the delay in  the re- 
accumulation of calcium following the action potential. 
In considering the effects of quinidine on the heart we encounter several 
new problems. We have seen that the effect of the drug on isolated cardiac 
sarcoplasmic reticulum was essentially the same as that observed with skeletal 
muscle preparations.  Yet,  contrary to  its  effect on  intact  skeletal  muscle, 
quinidine causes a  reduction in myocardial tension development. Since the 
activity of the  contractile protein complex of cardiac muscle,  like  that  of 
skeletal muscle, is a  function of the free intracellular calcium concentration 
(16), we might assume that any agent which inhibited the sarcotubular cal- 
cium pump would raise the free calcium concentration and thus cause an in- 
crease  in  tension  development.  This  assumption  is  implicit  in  Lee's  (29) 
attempt to explain the positive inotropic effect of cardiac glycosides in terms 964  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  5 2  •  i968 
of an inhibition of sarcotubular calcium transport. The validity of this assump- 
tion is  open to question.  As pointed out by Gertz et al.  (20),  the extent to 
which an increased calcium flux from sarcoplasmic reticulum to myoplasm 
leads  to  an increased myoplasmic calcium concentration will depend upon 
how well  other  potential  calcium  transport  systems in  the  cell  (e.g.  mito- 
chondria,  sarcolemma)  compete with  the  myofibrils for  the  available  free 
calcium. Thus different responses of skeletal and cardiac muscle to the same 
agent may reflect differences in calcium compartmentalization within the cell. 
The mitochondrial content of skeletal muscle, especially the amphibian mus- 
cle used in most experiments,  is  considerably less  than  that of mammalian 
heart muscle (30).  In view of the fact that the mitochondria can accumulate 
large quantities of calcium (31),  this difference may have important implica- 
tions for the regulation of intracellular calcium movement. The role of the 
sarcolemma in calcium transport is not clear. The recent radioautographic 
experiments of Winegrad (32) suggest that in skeletal muscle the main site of 
calcium exchange between intracellular  and  extracellular space  is  not  the 
sarcolemma but  the junction  between  the  terminal  cisternae  of the  sarco- 
plasmic reticulum and  the transverse tubules. There also seems to be some 
functional specialization  of different parts  of the sarcoplasmic reticulum of 
skeletal muscle (32). At present even less is known about intracellular calcium 
compartments  in  cardiac  muscle.  It  is  quite  conceivable  that  in  skeletal 
muscle changes in myoplasmic calcium concentration are an accurate reflec- 
tion of calcium fluxes out of the sarcoplasmic reticulum whereas in cardiac 
muscle  the  cooperative  action  of several  different compartments  must  be 
considered. Since the identifcation of these compartments and their kinetic 
parameters are unknown further speculation  on  this  point  is  probably not 
warranted. 
Recent studies of cardiac muscle mechanics provide another line of evidence 
that  the excitation-contraction coupling mechanism in  this  tissue differs in 
some fundamental respects from that  of skeletal muscle.  In  the electrically 
stimulated skeletal muscle the intensity of the active state  is  essentially in- 
variant (33). Alterations in muscle tension, whether in response to repetitive 
stimulation or drugs,  are mediated through changes in  the duration of the 
active state.  In contrast,  the studies of Sonnenblick  (34)  and Edman et al. 
(35)  have shown that alterations of cardiac contractility such as those pro- 
duced by changes in frequency of stimulation,  catecholamines, and cardiac 
glycosides are mediated through changes in intensity of the active state.  We 
assume  that  active  state  intensity in  both  skeletal  and  cardiac muscle is  a 
function of the myoplasmic calcium concentration (13,  35). This in turn de- 
pends  on the amount of calcium released from the sarcoplasmic reticulum. 
It follows that in skeletal muscle a  single action potential releases a  "satura- FRANKLIN FUCHS ZT AL.  Effect  of Quinidine on Sarcoplasmic Reticulum  965 
ting" amount of calcium. If the rate at which this calcium is restored to the 
sarcoplasmic reticulum is decreased the active state will be prolonged and the 
twitch tension increased. The active state intensity of cardiac muscle can be 
considerably  less  than  maximum depending on  the  inotropic  state  of the 
heart  (34,  35). On the basis of the above assumption the amount of calcium 
released from the sarcoplasmic reticulum during excitation is a variable which 
reflects the various physiological and pharmacological parameters known to 
alter  cardiac  contractility. The  basic  problem in  the regulation of cardiac 
contractility is to define the factors which determine the amount of calcium 
released from the sarcoplasmic reticulum during excitation.  !,i.! 
The hypothesis currently under consideration in this laboratory  is that the 
amount of calcium released during excitation-contraction coupling is  a  func- 
tion of the calcium content of the sarcoplasmic reticulum and that changes in 
the inotropic state of the heart are mediated through changes in the calcium 
content of the reticulum. This hypothesis is based on experiments of Briggs et 
al.  (36)  and  Gertz  et  al.  (20)  demonstrating a  depression  of  sarcotubular 
calcium transport associated with both barbiturate-induced heart failure and 
spontaneous  failure  (heart-lung  preparation).  This  depression  of  calcium 
transport, like the contractile failure, was reversible with ouabain. Gertz et al. 
(20)  proposed that if the calcium pump is inhibited calcium would flow out 
of the reticulum and  possibly be  shunted  to  compartments which are  not 
responsive to electrical stimulation. Thus less calcium would be available for 
coupling. 
The fact that another negative inotropic substance in addition to the bar- 
biturates, namely quinidine, inhibits calcium transport, provides support for 
the above hypothesis. Recently it has been shown that the t-blocking drugs, 
propranolol and pronethalol, both of which also depress cardiac contractility 
(7, 37), cause a marked inhibition of sarcotubular calcium accumulation (38, 
39).  Further systematic studies with a  variety of positive and negative ino- 
tropic  drugs would clearly  be  of interest  in  evaluating  the validity of this 
hypothesis. 
In a  recent paper Scales and McIntosh (40) noted that 2  X  10  -4 M quini- 
dine  caused  a  small  but  significant  increase  in  the  total  ATP-dependent 
calcium binding by skeletal muscle sarcoplasmic reticulum (in the absence of 
oxalate). However, Isaacson and Sandow (4) cite several brief observations in 
the  literature  suggesting  that  quinidine  and  quinine  can  displace  bound 
calcium from the sarcoplasmic reticulum. It is difficult to relate these observa- 
tions to our own since the experimental conditions and the quantities being 
measured were quite different. Because oxalate was present in all our experi- 
ments the data obtained were the unidirectional fluxes across the sarcotubular 
membrane (14). There is reason to believe that part of the ATP-dependent 966  THE  JOURNAL  OF  GENERAL PHYSIOLOGY  '  VOLUME 50  "  1968 
calcium uptake in the absence of oxalate may represent binding to the mem- 
brane rather than transport across the membrane (19,  41). The relationship 
between this binding and transport remains to be elucidated. 
As to the mechanism of action of quinidine, little can be said beyond the 
fact that the inhibition of transport is accompanied by an inhibition of the 
Ca++-activated ATPase of the sarcotubular membrane. Ells  and  Faulkner 
(25)  have similarly observed a quinidine inhibition of skeletal muscle micro- 
somal ATPase in the presence of low concentrations of calcium. Nayler (42, 
43) has shown that epinephrine and norepinephrine potentiated the binding 
of calcium to sarcotubular phospholipids. Thus alterations in calcium-phos- 
pholipid affinities may be of importance in the molecular mechanism of action 
of cardioactive drugs.  Inhibition  of the  Ca++-activated ATPase activity is 
probably related  to  the  finding that  phospholipids  are  essential for  sarco- 
tubular ATPase activity (44). 
Note  Added in Proof  After this paper was submitted for  publication  a  study by 
Carvalho  (J. Gen. Physiol.  1968. 52:622) appeared describing the effects of various 
drugs on the binding  of calcium to sarcotubular membanes. He found that quinine 
and quinidine  (1-5 mm) displaced both the passively bound calcium and  the  cal- 
cium bound in the presence of ATP. 
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of Health. 
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